Related Experiment Video
Updated: Oct 3, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Preconceptual leptin levels in gestational diabetes and hypertensive pregnancy
Antti Peltokorpi1, Lisinen Irina2, Viikari Liisa3
1Department of Clinical Medicine, University of Turku and Turku University Hospital, Turku, Finland.
Insights
Preconceptual leptin levels were significantly higher in women who later developed gestational diabetes (GDM) or pregnancy-induced hypertension (PIH/PE). These findings suggest leptin may be an early indicator for these pregnancy complications.
Area of Science:
- Reproductive endocrinology
- Maternal-fetal medicine
- Metabolic disorders in pregnancy
Background:
- Pregnancy-induced hypertension (PIH), preeclampsia (PE), and gestational diabetes (GDM) are common adverse pregnancy outcomes.
- Leptin, a hormone involved in metabolism and appetite, has been implicated in various pregnancy complications.
Purpose of the Study:
- To investigate whether preconceptual leptin levels differ between women who subsequently develop GDM or hypertensive disorders of pregnancy (PIH/PE) and those with uncomplicated pregnancies.
Main Methods:
- Utilized data from The Cardiovascular Risk in Young Finns Study and The Medical Birth Register of Finland.
- Analyzed preconceptual serum leptin levels in 293 women, categorized into GDM (n=71), PIH/PE (n=27), and control (n=201) groups.
Main Results:
- Preconceptual leptin levels were significantly elevated in both the GDM group (p < 0.0001) and the PIH/PE group (p = 0.0002) compared to controls.
- The association between higher leptin levels and GDM remained significant even after adjusting for Body Mass Index (BMI) (p = 0.0081).
Conclusions:
- Elevated preconceptual leptin levels are associated with an increased risk of developing gestational diabetes and pregnancy-induced hypertension/preeclampsia.
- Leptin may serve as a potential predictive biomarker for adverse pregnancy outcomes like GDM and PIH/PE.
Abstract:
Pregnancy - induced hypertension (PIH), preeclampsia (PE), and gestational diabetes (GDM) are common adverse outcomes in pregnancy.
Objective:
To find out whether preconceptual leptin levels differ in subsequent pregnancy between control vs. GDM and hypertensive pregnancy groups.
Materials And Methods:
Data was from The Cardiovascular Risk in Young Finns Study and The Medical Birth Register of Finland. Of 293 subjects 71 developed GDM, 27 PIH/PE and 201 were controls.
Results:
Leptin was higher in GDM (p < 0.0001) and PIH/PE (p = 0.0002) groups compared to control. GDM group was robust to BMI matching (p = 0,0081).
Conclusion:
Leptin was higher in GDM (p < 0.0001) and PIH/PE (p = 0.0002) groups compared to control. GDM group was robust to BMI matching (p = 0,0081).
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypoglycemia and Glucagon
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Obesity

